山东大学耳鼻喉眼学报 ›› 2026, Vol. 40 ›› Issue (5): 25-36.doi: 10.6040/j.issn.1673-3770.0.2025.515
• 儿童耳鼻咽喉头颈外科 • 上一篇
杨晓璐,周永青,李晓明,王苗,李震
YANG Xiaolu, ZHOU Yongqing, LI Xiaoming, WANG Miao, LI Zhen
摘要: 目的 采用单中心回顾性队列研究方法,回顾性分析儿童中耳胆脂瘤的临床病例特点及手术疗效,验证欧洲耳神经外科学/日本耳科学会(European academy of otology and neurotology/Japanese otological society, EAONO/JOS)分期指导个体化手术的有效性并识别术后复发的独立危险因素。 方法 纳入2005年1月1日至2024年12月31日收治的14岁以下儿童中耳胆脂瘤患者171例(177耳),采用回顾性分析方法提取患者临床表现、影像学特征、手术方式及术后随访结果等核心临床特征,对不同类型胆脂瘤特征、不同分期手术疗效等分类指标行分析,利用多因素 logistic 回归分析方法探究儿童中耳胆脂瘤术后复发的重要影响因素。 结果 儿童中耳胆脂瘤好发于男性,8~10岁为发病高峰,左右耳发病率无明显差异。主要临床表现为耳流脓(83.0%)及听力下降(71.9%),耳道分泌物恶臭(36.3%)为重要鉴别特征。并发症以耳后骨膜下脓肿相对多见。鼓膜松弛部穿孔多见(51.4%),板障型乳突为主(76.2%)。胆脂瘤易侵及上鼓室、鼓窦,其次为后鼓室及乳突,听骨链损伤以砧骨及砧镫关节同时受累最为常见。面神经鼓室段裸露比例较高(29.4%)。根据EAONO/JOS分期,Ⅱ期病变占比最高(89.3%)。术后完成随访150耳,随访时间0.5~14年,复发3耳(2.0%)。术后平均纯音听阈及气骨导差较术前明显改善(P均<0.001)。多因素分析显示,听骨链Ⅳ型损伤是术后复发的重要相关因素。 结论 儿童中耳胆脂瘤具有独特的临床与病理特征。依据EAONO/JOS分期选择个体化手术方案(Ⅰ期以上鼓室-鼓窦开放为主,Ⅱ~Ⅳ期以开放式乳突根治为主)可获得良好疗效。术后定期随访对监测对侧耳、及时处理填塞物残留、耳道膜性闭锁及早期发现复发胆脂瘤具有重要意义。
中图分类号:
| [1] Zeng N, Liang M, Yan S, et al. Transcanal endoscopic treatment for congenital middle ear cholesteatoma in children[J]. Medicine(Baltimore), 2022, 101(29): e29631. DOI: 10.1097/MD.0000000000029631 [2] Maharjan M, Rajbhandari S, Subba S, et al. Prevalence of cholesteatoma in school Children of nepal[J]. Int Arch Otorhinolaryngol, 2025, 29(4): 1-5. DOI: 10.1055/s-0045-1811514 [3] Dambergs K, Sumeraga G, Pilmane M. Comparison of tissue factors in the ontogenetic aspects of human cholesteatoma[J]. Diagnostics(Basel), 2024, 14(6):662. DOI: 10.3390/diagnostics14060662 [4] Mooney CP, Reddy R, Saxby A, et al. Endoscopic management of acquired paediatric cholesteatoma: a retrospective cohort study[J]. Aust J Otolaryngol, 2024, 7: 27. DOI:10.21037/ajo-23-53 [5] Kodama K, Hara M, Hasegawa M, et al. Two cases of spontaneous regression of congenital cholesteatomas[J]. Int J Pediatr Otorhinolaryngol, 2012, 76(1): 142-144. DOI: 10.1016/j.ijporl.2011.07.008 [6] Yung M, Tono T, Olszewska E, et al. EAONO/JOS joint consensus statements on the definitions, classification and staging of middle ear cholesteatoma[J]. J Int Adv Otol, 2017, 13(1): 1-8. DOI: 10.5152/iao.2017.3363 [7] 苏秋豫. 儿童和成人后天性中耳胆脂瘤的临床特点分析[D]. 郑州: 郑州大学, 2019: 26 [8] Saleh HA, Mills RP. Classification and staging of cholesteatoma[J]. Clin Otolaryngol Allied Sci, 1999, 24(4): 355-359. DOI:10.1046/j.1365-2273.1999.00272.x [9] Bonnard Å, Engmér Berglin C, Wincent J, et al. The risk of cholesteatoma in individuals with first-degree relatives surgically treated for the disease[J]. JAMA Otolaryngol Head Neck Surg, 2023, 149(5): 390-396. DOI:10.1001/jamaoto.2023.0048 [10] Djurhuus BD, Faber CE, Skytthe A. Decreasing incidence rate for surgically treated middle ear cholesteatoma in Denmark 1977-2007[J]. Dan Med Bull, 2010, 57(10): A4186 [11] Rosenfeld RM, Moura RL, Bluestone CD. Predictors of residual-recurrent cholesteatoma in children[J]. Arch Otolaryngol Head Neck Surg, 1992, 118(4): 384-391. DOI:10.1001/archotol.1992.01880040042008 [12] Bhutta MF, Williamson IG, Sudhoff HH. Cholesteatoma[J]. Bmj, 2011, 342(mar03 1): d1088. DOI:10.1136/bmj.d1088 [13] Morrison D, Kesser B. Congenital anomalies of the ear canal[J]. Otolaryngol Clin North Am, 2023, 56(5): 933-948. DOI: 10.1016/j.otc.2023.06.007 [14] Lasminingrum L, Mahdiani S, Makerto RD. Surgical treatment of external auditory canal cholesteatoma in congenital malformation of the ear: a case series[J]. Ann Med Surg(Lond), 2021, 70: 102880. DOI: 10.1016/j.amsu.2021.102880 [15] Djurhuus BD, Skytthe A, Faber CE, et al. Cholesteatoma risk in 8,593 orofacial cleft cases and 6,989 siblings: a nationwide study[J]. Laryngoscope, 2015, 125(5): 1225-1229. DOI: 10.1002/lary.25022 [16] Bergamaschi R, Bergonzoni C, Mazzanti L, et al. Hearing loss in Turner syndrome: results of a multicentric study[J]. J Endocrinol Invest, 2008, 31(9):779-783. DOI: 10.1007/BF03349257 [17] Lim DBN, Gault EJ, Kubba H, et al. Cholesteatoma has a high prevalence in Turner syndrome, highlighting the need for earlier diagnosis and the potential benefits of otoscopy training for paediatricians[J]. Acta Paediatr, 2014, 103(7): e282-e287. DOI:10.1111/apa.12622 [18] 邵剑波, 陈敏, 郝津生, 等. 儿童先天性及后天性中耳胆脂瘤临床特征分析[J]. 临床耳鼻咽喉头颈外科杂志, 2025, 39(2): 133-136. DOI: 10.13201/j.issn.2096-7993.2025.02.007 [19] 邵剑波, 陈敏, 郝津生, 等. 儿童中耳胆脂瘤不同手术方式复发率分析[J]. 中华耳科学杂志, 2020, 18(5): 825-828. DOI: 10.3969/j.issn.1672-2922.2020.05.002 [20] 徐斌, 付勇, 舒强. 儿童中耳胆脂瘤的临床特点及治疗[J]. 中华耳科学杂志, 2016, 14(1): 67-70. DOI:10.3969/j.issn.1672-2922.2016.01.014 [21] 张强, 解凤阳, 栾德恒, 等. 108例中耳炎患者患耳分泌物病原菌培养鉴定及药敏试验结果分析[J]. 山东医药, 2020, 60(12): 81-84. DOI: 10.3969/j.issn.1002-266X.2020.12.022 [22] Suttle TK, Els T, Toman J, et al. Chronic suppurative otitis media: a prospective descriptive study of the microbiology and antimicrobial susceptibility patterns[J]. Otolaryngol Head Neck Surg, 2024, 171(1): 90-97. DOI: 10.1002/ohn.708 [23] Bartos M, Urik M, Buresova L, et al. Bacteriome of the middle ear in children and young adults with cholesteatoma and retraction pocket: a pilot study[J]. OTO Open, 2025, 9(1): e70051. DOI:10.1002/oto2.70051 [24] Kulmakov SA, Soldatsky YL, Polunin MM, et al. Bacterial microbiota in exacerbation of chronic purulent otitis media in children[J]. Vestn Otorinolaringol, 2023, 88(5): 7-11. DOI: 10.17116/otorino2023880517 [25] Kroon VJ, Mes SW, Borggreven PA, et al. Cholesteatoma surgery in the pediatric population: remaining challenges in the era of mastoid obliteration[J]. Eur Arch Otorhinolaryngol, 2023, 280(4): 1713-1722. DOI: 10.1007/s00405-022-07669-0 [26] 苏秋豫, 郝少娟, 叶放蕾. 306例儿童中耳胆脂瘤的临床特点及手术方式[J]. 中华耳科学杂志, 2018, 16(4): 532-537. DOI:10.3969/j.issn.1672-2922.2018.04.019 [27] Kalia M, Dass A, Singhal SK, et al. Comparative study of cholesteatoma in paediatric and adult patients[J]. J Laryngol Otol, 2022, 136(8):765-768. DOI: 10.1017/S0022215122001104 [28] Schürmann M, Oppel F, Shao S, et al. Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism[J]. Cell Commun Signal, 2021, 19(1):25. DOI: 10.1186/s12964-020-00690-y [29] Schürmann M, Greiner JFW, Volland-Thurn V, et al. Stem cell-induced inflammation in cholesteatoma is inhibited by the TLR4 antagonist LPS-RS[J]. Cells, 2020, 9(1): 199. DOI:10.3390/cells9010199 [30] Kim H, Yoo SY, Choung YH, et al. Is transcanal tympanoplasty an appropriate surgical treatment for congenital middle ear cholesteatoma with ossicular involvement?[J]. Int J Pediatr Otorhinolaryngol, 2019, 116: 102-106. DOI:10.1016/j.ijporl.2018.10.030 [31] Agarwal N, Sudhakar KVK, Jain A, et al. A comparative study on mastoid cavity obliteration versus open mastoid cavity in modified radical mastoidectomy patients[J]. Int J Acad Med Pharm, 2023, 5(3): 530-535. DOI: 10.47009/jamp.2023.5.3.112 [32] Marchand G, Chatelet F, Atallah S, et al. EAONO/JOS, STAMCO, ChOLE & Potsic Staging of 271 pediatric cholesteatoma: evidence-based mod-pot staging system[J]. Laryngoscope, 2025, 135(2):908-919. DOI: 10.1002/lary.31837 [33] Solis-Pazmino P, Siepmann T, Scheffler P, et al. Canal wall up versus canal wall down mastoidectomy techniques in the pediatric population with cholesteatoma: a systematic review and meta-analysis of comparative studies[J]. Int J Pediatr Otorhinolaryngol, 2023,173:111658. DOI:10.1016/j.ijporl.2023.111658 [34] Chiao W, Chieffe D, Fina M. Endoscopic management of primary acquired cholesteatoma[J]. Otolaryngol Clin North Am, 2021, 54(1): 129-145. DOI:10.1016/j.otc.2020.09.014 [35] Basonbul RA, Ronner EA, Kozin ED, et al. Systematic review of endoscopic ear surgery outcomes for pediatric cholesteatoma[J]. Otol Neurotol, 2021, 42(1): 108-115. DOI: 10.1097/MAO.0000000000002876 [36] Adriaansens C, Bekkers S, Aarts MCJ. Determinants influencing cholesteatoma recurrence in daily practice:a retrospective analysis[J]. J Laryngol Otol, 2022, 136(2):119-124. DOI:10.1017/S0022215121003546 [37] Penaranda D, Cheng AG, Ahmad I. Pediatric ossiculoplasty and implications in cholesteatoma surgery[J]. Curr Opin Otolaryngol Head Neck Surg, 2025. DOI: 10.1097/MOO.0000000000001084 [38] James AL. Cholesteatoma severity determines the risk of recurrent paediatric cholesteatoma more than the surgical approach[J]. J Clin Med, 2024, 13(3): 836. DOI:10.3390/jcm13030836 [39] Massoud S, Farhat R, Abd Elhadi U, et al. Incidence rate and determinants of recurrent cholesteatoma following surgical management: a systematic review, subgroup, and meta-regression analysis[J]. Biomedicines, 2025, 13(10): 2506. DOI: 10.3390/biomedicines13102506 [40] Hassman-Poznańska E, Kurzyna A, Trzpis K, et al. The status of the contralateral ear in children with acquired cholesteatoma[J]. Acta Otolaryngol, 2012, 132(4): 404-408. DOI:10.3109/00016489.2011.646009 [41] Collins R, Ta NH, Jennings BA, et al. Cholesteatoma and family history: an international survey[J]. Clin Otolaryngol, 2020, 45(4): 500-505. DOI:10.1111/coa.13544 [42] Wang X, Guo J, Liu W, et al. Comparison of the EAONO/JOS, STAMCO and ChOLE cholesteatoma staging systems in the prognostic evaluation of acquired middle ear cholesteatoma in children[J]. Eur Arch Otorhinolaryngol, 2022, 279(12):5583-5590. DOI: 10.1007/s00405-022-07400-z [43] Simon F, Remangeon F, Loundon N, et al. Pediatric cholesteatoma follow-up: residual and recurrence in 239 cases with over 5-year hindsight[J]. Laryngoscope, 2024, 134(11):4789-4798. DOI: 10.1002/lary.31567 |
| [1] | 中国医师协会耳鼻咽喉头颈外科医师分会小儿学组,江苏省康复医学会听力与言语康复专业委员会,浙江省医学会听力学分会. 儿童突发性聋诊断和治疗专家共识(2026)[J]. 山东大学耳鼻喉眼学报, 2026, 40(5): 1-10. |
| [2] | 李琦,谷庆隆. 中国儿童耳鼻咽喉头颈外科发展现状与展望[J]. 山东大学耳鼻喉眼学报, 2026, 40(5): 11-17. |
| [3] | 姜玥,顾亚军,王俊国,钱晓云. 儿童阻塞性睡眠呼吸暂停低通气综合征相关代谢组学的进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(5): 18-24. |
| [4] | 刘君,闫京豫,陈巍,郑丽丽,陈秀红,胡晋平. 角膜塑形镜配戴患儿知信行潜在剖面特征及影响因素[J]. 山东大学耳鼻喉眼学报, 2026, 40(4): 105-110. |
| [5] | 张国民,王茂华,高松,吴文斌,虞幼军. 持续灌流模式耳内镜下粘连性中耳炎手术疗效分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 16-19. |
| [6] | 朱希倩,王佳,孙祖贤,冯建秀,张梦佳,赵颖,王宏,姜敏敏. 上海市杨浦区2022—2024年6~9岁学龄儿童屈光状态分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 102-109. |
| [7] | 宋艳玲,司元元,崔彦. 微量玻璃体切除治疗激光笔致儿童全层黄斑裂孔1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 144-147. |
| [8] | 刘南仙,杨泽垠,韩琳,张爱英,赵宇亮,薛静,孙怡君,邵永良. 视频脑电图在儿童复发性眩晕诊断中的意义[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 20-25. |
| [9] | 黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41. |
| [10] | 王华,张丰珍,龙婷,赵靖,李宏彬,王生才,王桂香. 后颅窝肿瘤术后儿童气管切开原因及预后转归分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 168-173. |
| [11] | 乐冰艳,邹剑,雷蕾,文巧,钱应雪. 儿童扁桃体微生物群与免疫调节及疾病关联[J]. 山东大学耳鼻喉眼学报, 2025, 39(4): 193-200. |
| [12] | 黄爱萍,王娟,王丽,耿江桥,王亚芳,温鑫. 儿童原发扁桃体Burkitt淋巴瘤累及上颌骨和肺1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 148-152. |
| [13] | 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58. |
| [14] | 付圣尧,陈敏,庞文会,李娜. 内镜辅助个体化手术入路治疗儿童鼻中线囊肿及瘘管[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 65-71. |
| [15] | 陈丹萍,何子键,虞幼军,周晓娓. 儿童突发性聋10年住院病例的疗效及预后相关因素分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 16-22. |
|
||